|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wu D, Zhang P, Ma J, Xu J, Yang L, Xu W, Que H, Chen M and Xu H: Serum biomarker panels for the diagnosis of gastric cancer. Cancer Med. 8:1576–1583. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu K, Song S, Fu T, Liu Y, Zhang H, Yan M, He Z, Zhang W, Su H, Li Z, et al: Spatiotemporal trends in the incidence of gastrointestinal neoplasms in Wuwei City of Northwestern China from 1995 to 2016: A hospital-based retrospective observational study. Front Oncol. 11(712857)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shetty A, Balaraju G, Shetty S and Pai CG: Diagnostic utility of alarm features in predicting malignancy in patients with dyspeptic symptoms. Indian J Gastroenterol. 40:183–188. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Repetto O, Maiero S, Magris R, Miolo G, Cozzi MR, Steffan A, Canzonieri V, Cannizzaro R and De Re V: Quantitative proteomic approach targeted to fibrinogen β Chain in tissue gastric carcinoma. Int J Mol Sci. 19(759)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Machlowska J, Baj J, Sitarz M, Maciejewski R and Sitarz R: Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 21(4012)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu C, Wang Y, Li L, He D, Chi J, Li Q, Wu Y, Zhao Y, Zhang S, Wang L, et al: Engineered extracellular vesicles and their mimetics for cancer immunotherapy. J Control Release. 349:679–698. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu Z, Su W, Ao J, Wang M, Jiang Q, He J, Gao H, Lei S, Nie J, Yan X, et al: Instant diagnosis of gastroscopic biopsy via deep-learned single-shot femtosecond stimulated Raman histology. Nat Commun. 13(4050)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Delgado-Guillena PG, Morales-Alvarado VJ, Elosua-González A, Murcia Pomares O, Pérez-Aisa A, Córdova H, Alcedo J, Calvet X and Fernández-Esparrach G: Gastroenterologists' attitudes on the detection and management of gastric premalignant conditions: Results of a nationwide survey in Spain. Eur J Cancer Prev. 30:431–436. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ray-Offor E and Obiorah CC: Helicobacter pylori and precancerous lesions of the stomach in a Nigerian Metropolis: A cohort study. Niger J Clin Pract. 21:375–379. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ji L, Liu Z, Zhou B, Cai Y, An F, Wang L, Lv Z, Xia M, Yang J, Yuan J, et al: Community-based pilot study of a screening program for gastric cancer in a Chinese population. Cancer Prev Res (Phila). 13:73–82. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D and Zhang H: Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer. 17(737)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Toh J, Hoppe MM, Thakur T, Yang H, Tan KT, Pang B, Ho S, Roy R, Ho KY, Yeoh KG, et al: Profiling of gastric cancer cell-surface markers to achieve tumour-normal discrimination. BMJ Open Gastroenterol. 7(e000452)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhao J, Zhou R, Zhang Q, Shu P, Li H, Wang X, Shen Z, Liu F, Chen W, Qin J and Sun Y: Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value. Zhonghua Wei Chang Wai Ke Za Zhi. 20:47–52. 2017.PubMed/NCBI(In Chinese).
|
|
15
|
Wang Z, Mo TM, Tian L and Chen JQ: Gastrin-17 combined with CEA, CA12-5 and CA19-9 improves the sensitivity for the diagnosis of gastric cancer. Int J Gen Med. 14:8087–8095. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shi XJ, Wei Y and Ji B: Systems biology of gastric cancer: Perspectives on the omics-based diagnosis and treatment. Front Mol Biosci. 7(203)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Niclauss N, Gütgemann I, Dohmen J, Kalff JC and Lingohr P: Novel biomarkers of gastric adenocarcinoma: Current research and future perspectives. Cancers (Basel). 13(5660)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shi F, Wu H, Qu K, Sun Q, Li F, Shi C, Li Y, Xiong X, Qin Q, Yu T, et al: Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer. Clin Proteomics. 15(18)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yoo MW, Park J, Han HS, Yun YM, Kang JW, Choi DY, Lee JW, Jung JH, Lee KY and Kim KP: Discovery of gastric cancer specific biomarkers by the application of serum proteomics. Proteomics. 17(1600332)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ahn HS, Sohn TS, Kim MJ, Cho BK, Kim SM, Kim ST, Yi EC and Lee C: SEPROGADIC-serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy. Sci Rep. 8(16892)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rostami-Nejad M, Rezaei-Tavirani M, Mansouri V, Akbari Z and Abdi S: Impact of proteomics investigations on gastric cancer treatment and diagnosis. Gastroenterol Hepatol Bed Bench. 12 (Suppl 1):S1–S7. 2019.PubMed/NCBI
|
|
22
|
Panner Selvam MK, Finelli R, Agarwal A and Henkel R: Proteomics and metabolomics-current and future perspectives in clinical andrology. Andrologia. 53(e13711)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu D, Zhou L, Huang L, Zuo Z, Ho V, Jin L, Lu Y, Chen X, Zhao J, Qian D, et al: Microfluidic integrated capacitive biosensor for C-reactive protein label-free and real-time detection. Analyst. 146:5380–5388. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu Y, Sang J, Zhou J and Fang Y: Comparative analysis of differences between preoperative endoscopic biopsy and postoperative pathological examination for diagnosis of gastric intraepithelial neoplasia. J Int Med Res. 49(300060521994929)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fernández-Coto DL, Gil J, Hernández A, Herrera-Goepfert R, Castro-Romero I, Hernández-Márquez E, Arenas-Linares AS, Calderon-Sosa VT, Sanchez-Aleman MÁ, Mendez-Tenorio A, et al: Quantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancer. J Proteomics. 186:15–27. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Huang A, Zhang M, Li T and Qin X: Serum proteomic analysis by tandem mass Tags (TMT) based quantitative proteomics in gastric cancer patients. Clin Lab. 64:855–866. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Svoronos C, Tsoulfas G, Souvatzi M and Chatzitheoklitos E: Prognostic value of COL6A3 in pancreatic adenocarcinoma. Ann Hepatobiliary Pancreat Surg. 24:52–56. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu W, Li L, Ye H, Tao H and He H: Role of COL6A3 in colorectal cancer. Oncol Rep. 39:2527–2536. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dai L, Li M, Zhang WL, Tang YJ, Tang YL and Liang XH: Fibroblasts in cancer dormancy: Foe or friend? Cancer Cell Int. 21(184)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang J and Pan W: The biological role of the collagen alpha-3 (VI) Chain and its cleaved C5 domain fragment endotrophin in cancer. Onco Targets Ther. 13:5779–5793. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lu Y, Kong X, Zhong W, Hu M and Li C: Diagnostic, therapeutic, and prognostic value of the thrombospondin family in gastric cancer. Front Mol Biosci. 8(647095)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bessa C, Matos P, Jordan P and Gonçalves V: Alternative splicing: Expanding the landscape of cancer biomarkers and therapeutics. Int J Mol Sci. 21(9032)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yu J, Zhang B, Zhang H, Qi Y and Wang Y, Wang W and Wang Y and Wang Y: E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Biochem Biophys Res Commun. 512:150–155. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huang Y, Li G, Wang K, Mu Z, Xie Q, Qu H, Lv H and Hu B: Collagen type VI alpha 3 Chain promotes epithelial-mesenchymal transition in bladder cancer cells via transforming growth factor β (TGF-β)/Smad pathway. Med Sci Monit. 24:5346–5354. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lee CW, Lin SE, Tsai HI, Su PJ, Hsieh CH, Kuo YC, Sung CM, Lin CY, Tsai CN and Yu MC: Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinoma. Oncol Lett. 15:559–567. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Casal JI and Bartolomé RA: Beyond N-cadherin, relevance of cadherins 5, 6 and 17 in cancer progression and metastasis. Int J Mol Sci. 20(3373)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Valverde A, Povedano E, Ruiz-Valdepeñas Montiel V, Yáñez-Sedeño P, Garranzo-Asensio M, Rodríguez N, Domínguez G, Barderas R, Campuzano S and Pingarrón JM: Determination of cadherin-17 in tumor tissues of different metastatic grade using a single incubation-step amperometric immunosensor. Anal Chem. 90:11161–11167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS and Park YY: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1. Oncotarget. 8:98887–98897. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu X, Huang Y, Yuan H, Qi X, Manjunath Y, Avella D, Kaifi JT, Miao Y, Li M, Jiang K and Li G: Disruption of oncogenic liver-intestine cadherin (CDH17) drives apoptotic pancreatic cancer death. Cancer Lett. 454:204–214. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kmeid M, Lukose G, Hodge K, Cho D, Kim KA and Lee H: Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: A pathological, clinical and outcome study. Histopathology. 79:768–778. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Altree-Tacha D, Tyrrell J and Haas T: CDH17 is a more sensitive marker for gastric adenocarcinoma than CK20 and CDX2. Arch Pathol Lab Med. 141:144–150. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Jiang XJ, Lin J, Cai QH, Zhao JF and Zhang HJ: CDH17 alters MMP-2 expression via canonical NF-κB signalling in human gastric cancer. Gene. 682:92–100. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Long ZW, Zhou ML, Fu JW, Chu XQ and Wang YN: Association between cadherin-17 expression and pathological characteristics of gastric cancer: A meta-analysis. World J Gastroenterol. 21:3694–3705. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Thorne RF, Wang Y, Zhang Y, Jing X, Zhang XD, de Bock CE and Oliveira CS: Evaluating nuclear translocation of surface receptors: Recommendations arising from analysis of CD44. Histochem Cell Biol. 153:77–87. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Chen C, Zhao S, Karnad A and Freeman JW: The biology and role of CD44 in cancer progression: Therapeutic implications. J Hematol Oncol. 11(64)2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Xu H, Niu M, Yuan X, Wu K and Liu A: CD44 as a tumor biomarker and therapeutic target. Exp Hematol Oncol. 9(36)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Senbanjo LT and Chellaiah MA: CD44: A multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front Cell Dev Biol. 5(18)2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Nimmakayala RK, Batra SK and Ponnusamy MP: Unraveling the journey of cancer stem cells from origin to metastasis. Biochim Biophys Acta Rev Cancer. 1871:50–63. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
He Y, Xue C, Yu Y, Chen J, Chen X, Ren F, Ren Z, Cui G and Sun R: CD44 is overexpressed and correlated with tumor progression in gallbladder cancer. Cancer Manag Res. 10:3857–3865. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tongtawee T, Wattanawongdon W, Simawaranon T, Kaewpitoon S, Kaengpenkae S, Jintabanditwong N, Tangjanyatham P, Ratchapol W, Kangwantas K, Dechsukhum C, et al: Expression of cancer stem cell marker CD44 and its polymorphisms in patients with chronic gastritis, precancerous gastric lesion, and gastric cancer: A cross-sectional multicenter study in Thailand. Biomed Res Int. 2017(438482)2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wang L, Zuo X, Xie K and Wei D: The role of CD44 and cancer stem cells. Methods Mol Biol. 1692:31–42. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hettinghouse A, Liu R and Liu CJ: Multifunctional molecule ERp57: From cancer to neurodegenerative diseases. Pharmacol Ther. 181:34–48. 2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Walsh RJ and Tan DSP: The role of immunotherapy in the treatment of advanced cervical cancer: Current status and future perspectives. J Clin Med. 10(4523)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kure S, Chiba T, Ebina A, Toda K, Jikuzono T, Motoda N, Mitani H, Sugitani I, Takeuchi K and Ohashi R: Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: A clinicopathological study of 1,139 cases with long-term follow-up. Endocr J. 69:273–281. 2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Shimoda T, Wada R, Kure S, Ishino K, Kudo M, Ohashi R, Fujita I, Uchida E, Yoshida H and Naito Z: Expression of protein disulfide isomerase A3 and its clinicopathological association in gastric cancer. Oncol Rep. 41:2265–2272. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Song D, Liu H, Wu J, Gao X, Hao J and Fan D: Insights into the role of ERp57 in cancer. J Cancer. 12:2456–2464. 2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, Meheus F, Verhoeven RHA, Vignat J, Laversanne M, et al: The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 47(101404)2022.PubMed/NCBI View Article : Google Scholar
|
